Utilizing genomic DNA purified from clotted blood samples for single nucleotide polymorphism genotyping

Archives of Pathology and Laboratory Medicine

Volumn 126, Issue 3, 2002, Pages 266-270

  Adkins, Karissa K ^a   Strom, Daniel A ^a   Jacobson, Thomas E ^a   Seemann, Cara R ^a   O'Brien, Darin P ^a   Heath, Ellen M ^a  

^a Gentra Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN;

ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PURIFICATION; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENOTYPE; HUMAN; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRAVIOLET SPECTROPHOTOMETRY;

DNA; GENE EXPRESSION PROFILING; GENETIC SCREENING; GENOME, HUMAN; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS;

EID: 0036186460     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Single nucleotide polymorphisms and the future of genetic epidemiology
2. The use of single nucleotide polymorphisms in the isolation of common disease genes
3. Mutation in blood coagulation factor V associated with resistance to activated protein C
4. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
5. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
6. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
7. Rapid detection of the CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction